SaneVax, Inc.

Safe, Affordable, Necessary & Effective Vaccines and Vaccination Practices

U.S. Govt. Knows Girls Won’t Get Third Toxic HPV Shot, So They Try PR-ing With Just Two

By 1 Comment

Truth Frequency News Published on September 8, 2011 by Sheree USA Today By HealthDay Two doses of the human papillomavirus (HPV) vaccine may offer just as much protection against cervical cancer as the three-dose regimen now being used, new U.S. government research shows. The findings stem from an analysis of data from the National Cancer […]

[Continue reading...]

Three HPV Vax Doses May Be Overkill

By Leave a Comment

Med Page Today By John Gever, Senior Editor, MedPage Today Published: September 08, 2011 Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston. Two doses of a bivalent vaccine against human papillomavirus (HPV) appeared just as effective in preventing persistent infections as the recommended three doses in young women, according to a […]

[Continue reading...]

Spinning the Spin Part II: Fewer girls develop cervical abnormalities after HPV vaccine

By Leave a Comment

The Marketing of Scientific Research & Studies By Leslie Carol Botha, Vice President of Public Relations, SaneVax Inc. My father, once a pharmaceutical packaging salesman and now an Alzheimer’s nursing home patient whose mental clarity declined rapidly post- flu vaccination – once told me ‘never believe in everything that is advertised.’ Truer advice was never […]

[Continue reading...]

National Cancer Institute Scientist Admits HPV Vaccines Have Little Value

By 1 Comment

By Heidi Stevenson In a misleading article attempting to promote the HPV vaccine, one of their scientists states that most vaccinated girls are at ‘pretty low risk’. The National Cancer Institute (NCI) has issued a bulletin claiming to answer early doubts about the HPV vaccine.(1) It doesn’t, of course, answer the real issue. The vaccine […]

[Continue reading...]

Behind the Scenes: The Evolution of an HPV Industry

By 3 Comments

By Norma Erickson, President of SaneVax Inc. The first papillomavirus was discovered in the 1930’s by Dr. Richard E. Shope. It was the cottontail rabbit papillomavirus, or the Shope papillomavirus, which occurred in warts that frequently developed into cancerous tumors1. Dr. Shope was able to isolate the virus, inject it into other rabbits and produce […]

[Continue reading...]

Study Estimates Overall HPV Prevalence in U.S. Women

By Leave a Comment

Adapted from the NCI Cancer Bulletin, vol. 4/no. 10, March 6, 2007 (see the current issue 3). Data from the National Health and Nutrition Examination Survey (NHANES) published in the February 28, 2007, Journal of the American Medical Association (JAMA) have provided the first national estimate of the prevalence of human papillomavirus (HPV) infection among […]

[Continue reading...]

Rogue virus in the vaccine

By Leave a Comment

By William Carlsen, Chronicle Staff Writer Early polio vaccine harbored virus now feared to cause cancer in humans. A growing number of medical researchers fear that a monkey virus that contaminated polio vaccine given to tens of millions of Americans in the 1950s and ’60s may be causing rare human cancers. For four decades, government […]

[Continue reading...]

Human Papillomavirus (HPV) Vaccines

By Leave a Comment

Published by the National Cancer Institute (NCI) What are human papillomaviruses?  Human papillomaviruses (HPVs) are a group of more than 100 related viruses. They are called papillomaviruses because certain types may cause warts, or papillomas, which are benign (noncancerous) tumors. The HPVs that cause the common warts that grow on hands and feet are different from […]

[Continue reading...]

Private-Public Partnerships in Cancer Vaccine Research

By Leave a Comment

By Aleea Farrakh, originally published in “Benchmarks” June 2008 Even though the National Cancer Institute is the leading Federal government agency for cancer research, it is hardly the sole contributor in the fight against cancer. Other government agencies, non-profit organizations, academia and private industry all play critical roles in helping find a cure for the disease. […]

[Continue reading...]

HPV screen-and-treat-intervention effective in cervical cancer prevention

By Leave a Comment

Journal of the National Cancer Institute Press Release 30 September 2010 Women in South Africa who underwent human papillomavirus (HPV) DNA-based testing or visual inspection of the cervix followed by treatment of test-positive women with cryotherapy had a statistically significant reduction in high grade cervical cancer precursors, compared with women in a control group, according […]

[Continue reading...]

SaneVax urges FDA and NCI to establish a reliable HPV genotyping test for virology-based cervical cancer prevention in patient care

By Leave a Comment

By:  Norma Erickson 06 November 2010 Last Tuesday, the SaneVax team sent a letter to Dr. Margaret Hamburg, FDA Commissioner, and Dr. Harold E. Varmus, Director of the National Cancer Institute (NCI), requesting the establishment of a reliable human papillomavirus (HPV) genotyping test to support the national virology-based cervical cancer prevention program for patient care. […]

[Continue reading...]

Conflicts of Interest in the Losing Cancer War

By Leave a Comment

Posted by Norma Erickson, SaneVax 15 September 2010   This article was written by Samuel S. Epstein, MD, Chairman of the Cancer Prevention Coalition, and Quentin D. Young, MD, Chairman of the Health and Medicine Policy Research Group. Although it was originally published on 4 March 2004, the information contained within is still timely. It […]

[Continue reading...]

NCI on Cervical Cancer Prevention and HPV vaccines: What’s a Woman to do?

By Leave a Comment

By:  Norma Erickson 31 August 2010 The following is a direct quote from a recently revised copy of “Cervical Cancer Prevention, Health Professional Version,” published by the National Cancer Institute (NCI): “The finding of HPV viral DNA integrated in most cellular genomes of cervical carcinomas supports epidemiologic data linking this agent to cervical cancer however, […]

[Continue reading...]

News

Videos

Contact